Clinical Trials Logo

Filter by:
NCT ID: NCT03676855 Recruiting - Clinical trials for Morbidly Adherent Placenta

Comparison Between Bladder Dissection Before and After Uterine Incision in Cesarean Section for Morbidly Adherent Placenta

Start date: March 31, 2018
Phase: N/A
Study type: Interventional

Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy

NCT ID: NCT03675802 Recruiting - GYN Disorders Clinical Trials

Cervical Preparation in Hysteroscopy

Start date: September 23, 2018
Phase: N/A
Study type: Interventional

The hysteroscopy was performed in the proliferativephase of the menstrual cycle. The patients were given generalintravenous anesthesia (propofol/fentanyl) after the vulvar and the vaginal area had been disinfected with a 7.5% Betadinesolution by the surgical nurse All operations were performed by the same surgeon to avoid possible discrepancies between different surgeons.

NCT ID: NCT03675659 Recruiting - Clinical trials for Temporomandibular Joint Disorders

Intra-articular Magnesium Sulfate for Tmj Dysfunction

Start date: September 9, 2017
Phase: Early Phase 1
Study type: Interventional

mixing the magnesium sulfate with dextrose for management of tmj pain will be studied using intra-articular injection of the solution

NCT ID: NCT03666078 Recruiting - Clinical trials for Delivery,Complication,Fetal

Assessment of Maternal and Perinatal Morbidity and Mortality in Vaginal and Cesarean Delivery

Start date: July 15, 2018
Phase:
Study type: Observational [Patient Registry]

This study will be done at Ain Shams university maternity hospital to identify the significant risk of maternal intensive care unit admission, need for advanced surgery, postpartum hemorrhage, need for blood transfusion, febrile morbidity, neonatal intensive care unit admission (NICU), need for neonatal intubation and low APGAR scoring in both vaginal and cesarean section .and this will lead us to know if cesarean section rates in our unit is a safe alternative to vaginal delivery and which of both maneuvers will introduce fewer hazards to mother and fetus.

NCT ID: NCT03664115 Recruiting - Lung Cancer Clinical Trials

Itraconazole in Non Small Cell Lung Cancer

Start date: July 2, 2018
Phase: Phase 2
Study type: Interventional

Circulating levels of angiogenic factors have been correlated with aggressive tumor growth, prediction of metastasis and prognosis in a wide range of solid tumors, including non-small cell lung cancer. Food and Drug Administration (FDA) approved Itraconazole as an anti-angiogenic agent including both Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), and inhibited phosphorylation of the primary angiogenic receptors for these factors in 2007 and also known as an inhibitor of Hedgehog signalling, AKT (protein kinase B)/mechanistic target of rapamycin (mTOR) signaling adding its induction of autophagic cell death function based on cellular and laboratory studies, and allowed its use in phase II trials in prostate, lung and skin cancer. Itraconazole also interferes directly with mitochondrial Adenosine triphosphate (ATP) production, leading to the activation of the adenosine monophosphate (AMP) -activated protein kinase pathway and subsequent inhibition of mTOR pathway (Head et al., 2015). Testing Itraconazole on experimental settings was associated also with tumor hypoxia, as proved by induction of tumor-specific expression of Hypoxia-inducible factor 1-alpha (HIF1α), as well as decreased tumor micro-vessel load

NCT ID: NCT03664050 Recruiting - Clinical trials for Induction of Ovulation

Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary

Start date: January 1, 2018
Phase: Phase 3
Study type: Interventional

The aim of this work is to compare the clinical outcomes of letrozole with laparoscopic ovarian drilling (LOD) in patients with clomiphene-citrate-resistant polycystic ovary syndrome (PCOS).

NCT ID: NCT03661957 Recruiting - Marginal Bone Loss Clinical Trials

Non Grafted Maxillary Sinus Floor Elevation With Implant Placement Versus the Use of Short Endosseous Implants

Start date: September 2018
Phase: N/A
Study type: Interventional

Assessment the need for sinus floor elevation when restoring atrophic posterior maxilla or it will be enough to use of short implant

NCT ID: NCT03661658 Recruiting - Marginal Bone Loss Clinical Trials

Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants

Start date: September 2018
Phase: N/A
Study type: Interventional

Assess the long term stability of short dental implants in comparison to standard implants inserted simultaneously with inferior alveolar nerve lateralization.

NCT ID: NCT03660020 Recruiting - Postoperative Pain Clinical Trials

Ultrasound Guided Erector Spinae Plane Block in Breast Surgery

Start date: May 19, 2018
Phase: N/A
Study type: Interventional

hyalorounidase will be added to local anaesthetics in patients undergoing mastectomy and effect on local anaesthetic spread will be studied under floroscope

NCT ID: NCT03656016 Recruiting - Cerebrospinal Fluid Clinical Trials

Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.

Start date: November 25, 2018
Phase:
Study type: Observational

Cerebrospinal fluid is a clear, colorless fluid that circulates in the cranial and spinal subarachnoid spaces, located between the pia and arachnoid matters. It is mainly produced by the choroid plexus, while lesser amount produced by the ependymal cells lining the ventricles. Its function includes cushioning and lubrication of the central nervous system, circulation of nutrients and waste collection providing basic mechanical and immunological protection to the brain.